Clinical Trial Results: Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hyperpolarized 13C-pyruvate metabolic MRI in prostate cancer; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2026-07-15